GENOVAC Trademark

Trademark Overview


On Tuesday, April 26, 2022, a trademark application was filed for GENOVAC with the United States Patent and Trademark Office. The USPTO has given the GENOVAC trademark a serial number of 97382291. The federal status of this trademark filing is REGISTERED as of Tuesday, June 6, 2023. This trademark is owned by Genovac Antibody Discovery LLC. The GENOVAC trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Biomanufacturing for others, namely, manufacturing of antibodies, proteins, and plasmids using biological organisms in the manufacturing process

Biotechnology research; Development of new technology for others in the field of biotechnology and pharmaceuticals; Laboratory research services relating to pharmaceuticals; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing information on the subject of scientific research in the field of biochemistry and biotechnology
genovac

General Information


Serial Number97382291
Word MarkGENOVAC
Filing DateTuesday, April 26, 2022
Status700 - REGISTERED
Status DateTuesday, June 6, 2023
Registration Number7074180
Registration DateTuesday, June 6, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Goods and ServicesBiomanufacturing for others, namely, manufacturing of antibodies, proteins, and plasmids using biological organisms in the manufacturing process
Goods and ServicesBiotechnology research; Development of new technology for others in the field of biotechnology and pharmaceuticals; Laboratory research services relating to pharmaceuticals; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing information on the subject of scientific research in the field of biochemistry and biotechnology

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code040
First Use Anywhere DateSunday, November 1, 2020
First Use In Commerce DateSunday, November 1, 2020

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code042
First Use Anywhere DateSunday, November 1, 2020
First Use In Commerce DateSunday, November 1, 2020

Trademark Owner History


Party NameGenovac Antibody Discovery LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressFargo, ND 58102

Party NameGenovac Antibody Discovery LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressFargo, ND 58102

Party NameGenovac Antibody Discovery LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFargo, ND 58102

Trademark Events


Event DateEvent Description
Tuesday, June 6, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 6, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 13, 2023ASSIGNED TO EXAMINER
Monday, May 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 29, 2022NEW APPLICATION ENTERED